arrow
J

Jeffrey B. Geske

mayo clinic
H指数:43
被引数:7,274

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Risk Factors for Left Atrial Thrombus in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation

肥厚型心肌病合并心房颤动患者左心房血栓的危险因素

2026-06-100
PRE
Long-Term Favorable Cardiac Remodeling in Obstructive Hypertrophic Cardiomyopathy Patients Treated With Mavacamten for up to 128 Weeks

接受Mavacamten治疗长达128周的梗阻性肥厚型心肌病患者长期有利的心脏重塑

2025-09-160
PRE
ID: 4343067 ARTIFICIAL INTELLIGENCE ELECTROCARDIOGRAPHY PREDICTS UNDIAGNOSED HYPERTROPHIC CARDIOMYOPATHY IN POST-HOC ANALYSIS OF CARDIAC ARREST SURVIVORS

ID: 4343067 人工智能心电图预测心搏骤停幸存者中未诊断的心肌肥厚症:事后分析

2025-09-030
OAAI
Artificial intelligence electrocardiography and sudden death risk factors among cardiac arrest survivors diagnosed with hypertrophic cardiomyopathy

人工智能心电图和心脏骤停幸存者中肥厚型心肌病患者的猝死危险因素

2025-09-020
OAAI
Atrioventricular node ablation for refractory atrial fibrillation in patients with hypertrophic cardiomyopathy: a case-control study

对于肥厚型心肌病患者的难治性心房颤动进行房室结消融:一项病例对照研究

2025-09-010
OAAI
Echocardiographic Changes With Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy

在非梗阻性肥厚型心肌病中 mavacamten 的超声心动图变化

JACC
IF0
2025-08-270
PRE
Artificial intelligence–enhanced electrocardiogram diastolic function grade predicts post–septal myectomy mortality in hypertrophic cardiomyopathy

人工智能增强的心电图舒张功能分级可预测肥厚型心肌病室间隔心肌切开术后的死亡率

2025-05-280
PRE
The incremental role of late gadolinium enhancement in risk stratifying high risk patients with hypertrophic cardiomyopathy

晚期钆增强在风险分层高风险肥厚型心肌病患者中的增量作用

2025-05-030
PRE